NeuroExercise : The Effect of a 12-Month Exercise Intervention on Cognition in Mild Cognitive Impairment-A Multicenter Randomized Controlled Trial
Copyright © 2021 Stuckenschneider, Sanders, Devenney, Aaronson, Abeln, Claassen, Guinan, Lawlor, Meeusen, Montag, Olde Rikkert, Polidori, Reuter, Schulz, Vogt, Weber, Kessels and Schneider..
Exercise intervention studies in mild cognitive impairment (MCI), a prodromal stage of Alzheimer's disease (AD), have demonstrated inconsistent yet promising results. Addressing the limitations of previous studies, this trial investigated the effects of a 12-month structured exercise program on the progression of MCI. The NeuroExercise study is a multicenter randomized controlled trial across three European countries (Ireland, Netherlands, Germany). Hundred and eighty-three individuals with amnestic MCI were included and were randomized to a 12-month exercise intervention (3 units of 45 min) of either aerobic exercise (AE; n = 60), stretching and toning exercise (ST; n = 65) or to a non-exercise control group (CG; n = 58). The primary outcome, cognitive performance, was determined by an extensive neuropsychological test battery. For the primary complete case (CC) analyses, between-group differences were analyzed with analysis of covariance under two conditions: (1) the exercise group (EG = combined AE and ST groups) compared to the CG and (2) AE compared to ST. Primary analysis of the full cohort (n = 166, 71.5 years; 51.8% females) revealed no between-group differences in composite cognitive score [mean difference (95% CI)], 0.12 [(-0.03, 0.27), p = 0.13] or in any cognitive domain or quality of life. VO2 peak was significantly higher in the EG compared to the CG after 12 months [-1.76 (-3.39, -0.10), p = 0.04]. Comparing the two intervention groups revealed a higher VO2peak level in the aerobic exercise compared to the stretching and toning group, but no differences for the other outcomes. A 12-month exercise intervention did not change cognitive performance in individuals with amnestic MCI in comparison to a non-exercise CG. An intervention effect on physical fitness was found, which may be an important moderator for long term disease progression and warrants long-term follow-up investigations. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT02913053, identifier: NCT02913053.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Frontiers in aging neuroscience - 12(2020) vom: 08., Seite 621947 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stuckenschneider, Tim [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aerobic exercise |
---|
Anmerkungen: |
Date Revised 02.02.2021 published: Electronic-eCollection ClinicalTrials.gov: NCT02913053 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fnagi.2020.621947 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320806324 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320806324 | ||
003 | DE-627 | ||
005 | 20231225174413.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fnagi.2020.621947 |2 doi | |
028 | 5 | 2 | |a pubmed24n1069.xml |
035 | |a (DE-627)NLM320806324 | ||
035 | |a (NLM)33519425 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stuckenschneider, Tim |e verfasserin |4 aut | |
245 | 1 | 0 | |a NeuroExercise |b The Effect of a 12-Month Exercise Intervention on Cognition in Mild Cognitive Impairment-A Multicenter Randomized Controlled Trial |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 02.02.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a ClinicalTrials.gov: NCT02913053 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2021 Stuckenschneider, Sanders, Devenney, Aaronson, Abeln, Claassen, Guinan, Lawlor, Meeusen, Montag, Olde Rikkert, Polidori, Reuter, Schulz, Vogt, Weber, Kessels and Schneider. | ||
520 | |a Exercise intervention studies in mild cognitive impairment (MCI), a prodromal stage of Alzheimer's disease (AD), have demonstrated inconsistent yet promising results. Addressing the limitations of previous studies, this trial investigated the effects of a 12-month structured exercise program on the progression of MCI. The NeuroExercise study is a multicenter randomized controlled trial across three European countries (Ireland, Netherlands, Germany). Hundred and eighty-three individuals with amnestic MCI were included and were randomized to a 12-month exercise intervention (3 units of 45 min) of either aerobic exercise (AE; n = 60), stretching and toning exercise (ST; n = 65) or to a non-exercise control group (CG; n = 58). The primary outcome, cognitive performance, was determined by an extensive neuropsychological test battery. For the primary complete case (CC) analyses, between-group differences were analyzed with analysis of covariance under two conditions: (1) the exercise group (EG = combined AE and ST groups) compared to the CG and (2) AE compared to ST. Primary analysis of the full cohort (n = 166, 71.5 years; 51.8% females) revealed no between-group differences in composite cognitive score [mean difference (95% CI)], 0.12 [(-0.03, 0.27), p = 0.13] or in any cognitive domain or quality of life. VO2 peak was significantly higher in the EG compared to the CG after 12 months [-1.76 (-3.39, -0.10), p = 0.04]. Comparing the two intervention groups revealed a higher VO2peak level in the aerobic exercise compared to the stretching and toning group, but no differences for the other outcomes. A 12-month exercise intervention did not change cognitive performance in individuals with amnestic MCI in comparison to a non-exercise CG. An intervention effect on physical fitness was found, which may be an important moderator for long term disease progression and warrants long-term follow-up investigations. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT02913053, identifier: NCT02913053 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Alzheimer's disease | |
650 | 4 | |a aerobic exercise | |
650 | 4 | |a cognition | |
650 | 4 | |a non-pharmacological treatment | |
650 | 4 | |a quality of life | |
700 | 1 | |a Sanders, Marit L |e verfasserin |4 aut | |
700 | 1 | |a Devenney, Kate E |e verfasserin |4 aut | |
700 | 1 | |a Aaronson, Justine A |e verfasserin |4 aut | |
700 | 1 | |a Abeln, Vera |e verfasserin |4 aut | |
700 | 1 | |a Claassen, Jurgen A H R |e verfasserin |4 aut | |
700 | 1 | |a Guinan, Emer |e verfasserin |4 aut | |
700 | 1 | |a Lawlor, Brian |e verfasserin |4 aut | |
700 | 1 | |a Meeusen, Romain |e verfasserin |4 aut | |
700 | 1 | |a Montag, Christian |e verfasserin |4 aut | |
700 | 1 | |a Olde Rikkert, Marcel G M |e verfasserin |4 aut | |
700 | 1 | |a Polidori, M Cristina |e verfasserin |4 aut | |
700 | 1 | |a Reuter, Martin |e verfasserin |4 aut | |
700 | 1 | |a Schulz, Ralf-Joachim |e verfasserin |4 aut | |
700 | 1 | |a Vogt, Tobias |e verfasserin |4 aut | |
700 | 1 | |a Weber, Bernd |e verfasserin |4 aut | |
700 | 1 | |a Kessels, Roy P C |e verfasserin |4 aut | |
700 | 1 | |a Schneider, Stefan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in aging neuroscience |d 2009 |g 12(2020) vom: 08., Seite 621947 |w (DE-627)NLM198856024 |x 1663-4365 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2020 |g day:08 |g pages:621947 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fnagi.2020.621947 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2020 |b 08 |h 621947 |